Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Frank

Showing results (91-100 of 383) with videos related to

Pageof 39
Sort By:
Physics in Medicine and Biology|April 30, 2014
MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapyTze Yee Lim, R Jason Stafford, Rajat J Kudchadker, et al.
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
Medical Physics|July 3, 2016
Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessmentTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
Brachytherapy|March 13, 2017
Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imagingGeoffrey V Martin, Thomas J Pugh, Usama Mahmood, et al.
Brachytherapy|March 8, 2013
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trialSteven P Register, Rajat J Kudchadker, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2012
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatmentSteven J Frank, Mary J Johansen, Karen S Martirosyan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2024
Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton TherapyWilliam F Hartsell, Charles B Simone, Deborah Godes, et al.
Brachytherapy|September 27, 2014
Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafilThomas J Pugh, Usama Mahmood, David A Swanson, et al.
Clinical and Translational Radiation Oncology|December 25, 2025
Evaluation of organ-specific relative biological effectiveness of proton therapy using radiation-induced pneumonitis as an endpointLi Liao, Ting Xu, Mei Chen, et al.
Brachytherapy|May 15, 2017
Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markersGeoffrey V Martin, Thomas J Pugh, Usama Mahmood, et al.
Pageof 39

Showing results (91-100 of 383) with videos related to

Sort By:
Pageof 39
Physics in Medicine and Biology|April 30, 2014
MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapyTze Yee Lim, R Jason Stafford, Rajat J Kudchadker, et al.
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
Medical Physics|July 3, 2016
Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessmentTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
Brachytherapy|March 13, 2017
Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imagingGeoffrey V Martin, Thomas J Pugh, Usama Mahmood, et al.
Brachytherapy|March 8, 2013
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trialSteven P Register, Rajat J Kudchadker, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2012
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatmentSteven J Frank, Mary J Johansen, Karen S Martirosyan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2024
Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton TherapyWilliam F Hartsell, Charles B Simone, Deborah Godes, et al.
Brachytherapy|September 27, 2014
Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafilThomas J Pugh, Usama Mahmood, David A Swanson, et al.
Clinical and Translational Radiation Oncology|December 25, 2025
Evaluation of organ-specific relative biological effectiveness of proton therapy using radiation-induced pneumonitis as an endpointLi Liao, Ting Xu, Mei Chen, et al.
Brachytherapy|May 15, 2017
Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markersGeoffrey V Martin, Thomas J Pugh, Usama Mahmood, et al.
Pageof 39